Haidar M Al-Khazali, Rune H Christensen, Håkan Ashina
{"title":"创伤后头痛和偏头痛的临床比较:横断面研究。","authors":"Haidar M Al-Khazali, Rune H Christensen, Håkan Ashina","doi":"10.1177/03331024251331605","DOIUrl":null,"url":null,"abstract":"<p><p>ObjectiveTo compare clinical characteristics, treatment patterns, and patient-reported outcome measures (PROMs) in persons with persistent post-traumatic headache (PTH) and those with episodic or chronic migraine (with and without medication-overuse headache).MethodsThis cross-sectional study included adults with persistent PTH following mild traumatic brain injury and adults with episodic or chronic migraine. Information on headache features, treatment patterns, and PROMs were collected via semi-structured interviews and standardized questionnaires, including the HIT-6, MIDAS, HADS, ASC-12, CSI, WHODAS-2.0, NDI, and ODI.ResultsA total of 132 participants with persistent PTH and 751 with migraine were enrolled. On average, participants with persistent PTH reported 27.2 ± 9.3 monthly headache days, and 93.9% had a migraine-like phenotype. Compared with episodic migraine, the persistent PTH group had higher MIDAS scores (72.5 [IQR, 28.0-156.0] vs. 40.0 [IQR, 20.0-62.8]; <i>P</i> < 0.001), HADS-Anxiety (6.0 [IQR, 3.3-9.0] vs. 5.0 [IQR, 3.0-7.0]; <i>P</i> = 0.003), higher HADS-Depression scores (6.0 [IQR, 3.0-9.0] vs. 3.0 [IQR, 1.0-5.0]; <i>P</i> < 0.001), CSI (67.2 [SD, 15.0] vs. 57.4 [SD, 12.5]; <i>P</i> = 0.002), WHODAS-2.0 (41.0 [IQR, 15.5-68.5] vs. 22.0 [IQR, 10.0-35.0]; <i>P </i>< 0.001), and NDI (21.0 [IQR, 16.0-27.0] vs. 14.5 [IQR, 8.0-22.0]; <i>P </i>= 0.007). No marked differences were noted between the PTH group and chronic migraine groups.ConclusionsPersons with persistent PTH show similar disability and headache profiles to those with chronic migraine. These findings underscore the need for targeted management strategies, similar to those used in chronic migraine care.</p>","PeriodicalId":10075,"journal":{"name":"Cephalalgia","volume":"45 4","pages":"3331024251331605"},"PeriodicalIF":4.6000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical comparisons between post-traumatic headache and migraine: A cross-sectional study.\",\"authors\":\"Haidar M Al-Khazali, Rune H Christensen, Håkan Ashina\",\"doi\":\"10.1177/03331024251331605\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>ObjectiveTo compare clinical characteristics, treatment patterns, and patient-reported outcome measures (PROMs) in persons with persistent post-traumatic headache (PTH) and those with episodic or chronic migraine (with and without medication-overuse headache).MethodsThis cross-sectional study included adults with persistent PTH following mild traumatic brain injury and adults with episodic or chronic migraine. Information on headache features, treatment patterns, and PROMs were collected via semi-structured interviews and standardized questionnaires, including the HIT-6, MIDAS, HADS, ASC-12, CSI, WHODAS-2.0, NDI, and ODI.ResultsA total of 132 participants with persistent PTH and 751 with migraine were enrolled. On average, participants with persistent PTH reported 27.2 ± 9.3 monthly headache days, and 93.9% had a migraine-like phenotype. Compared with episodic migraine, the persistent PTH group had higher MIDAS scores (72.5 [IQR, 28.0-156.0] vs. 40.0 [IQR, 20.0-62.8]; <i>P</i> < 0.001), HADS-Anxiety (6.0 [IQR, 3.3-9.0] vs. 5.0 [IQR, 3.0-7.0]; <i>P</i> = 0.003), higher HADS-Depression scores (6.0 [IQR, 3.0-9.0] vs. 3.0 [IQR, 1.0-5.0]; <i>P</i> < 0.001), CSI (67.2 [SD, 15.0] vs. 57.4 [SD, 12.5]; <i>P</i> = 0.002), WHODAS-2.0 (41.0 [IQR, 15.5-68.5] vs. 22.0 [IQR, 10.0-35.0]; <i>P </i>< 0.001), and NDI (21.0 [IQR, 16.0-27.0] vs. 14.5 [IQR, 8.0-22.0]; <i>P </i>= 0.007). No marked differences were noted between the PTH group and chronic migraine groups.ConclusionsPersons with persistent PTH show similar disability and headache profiles to those with chronic migraine. These findings underscore the need for targeted management strategies, similar to those used in chronic migraine care.</p>\",\"PeriodicalId\":10075,\"journal\":{\"name\":\"Cephalalgia\",\"volume\":\"45 4\",\"pages\":\"3331024251331605\"},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cephalalgia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/03331024251331605\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/4/29 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cephalalgia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/03331024251331605","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/29 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的比较持续性创伤后头痛(PTH)患者与发作性或慢性偏头痛(伴或不伴药物滥用性头痛)患者的临床特征、治疗模式和患者报告的预后指标(PROMs)。方法本横断面研究包括轻度外伤性脑损伤后持续性PTH的成人和发作性或慢性偏头痛的成人。通过半结构化访谈和标准化问卷(包括HIT-6、MIDAS、HADS、ASC-12、CSI、WHODAS-2.0、NDI和ODI)收集有关头痛特征、治疗模式和PROMs的信息。结果共纳入了132例持续性甲状旁腺激素患者和751例偏头痛患者。平均而言,持续性PTH患者每月头痛天数为27.2±9.3天,93.9%的患者有偏头痛样表型。与发作性偏头痛相比,持续性PTH组的MIDAS评分更高(72.5 [IQR, 28.0-156.0] vs. 40.0 [IQR, 20.0-62.8];P = 0.003),较高的HADS-Depression评分(6.0 [IQR, 3.0-9.0] vs. 3.0 [IQR, 1.0-5.0];P P = 0.002), whodas - 2.0(41.0(差,15.5 - -68.5)和22.0(差,10.0 - -35.0);p = 0.007)。PTH组与慢性偏头痛组间无明显差异。结论持续性甲状旁腺激素患者与慢性偏头痛患者表现出相似的残疾和头痛特征。这些发现强调了有针对性的管理策略的必要性,类似于慢性偏头痛的治疗。
Clinical comparisons between post-traumatic headache and migraine: A cross-sectional study.
ObjectiveTo compare clinical characteristics, treatment patterns, and patient-reported outcome measures (PROMs) in persons with persistent post-traumatic headache (PTH) and those with episodic or chronic migraine (with and without medication-overuse headache).MethodsThis cross-sectional study included adults with persistent PTH following mild traumatic brain injury and adults with episodic or chronic migraine. Information on headache features, treatment patterns, and PROMs were collected via semi-structured interviews and standardized questionnaires, including the HIT-6, MIDAS, HADS, ASC-12, CSI, WHODAS-2.0, NDI, and ODI.ResultsA total of 132 participants with persistent PTH and 751 with migraine were enrolled. On average, participants with persistent PTH reported 27.2 ± 9.3 monthly headache days, and 93.9% had a migraine-like phenotype. Compared with episodic migraine, the persistent PTH group had higher MIDAS scores (72.5 [IQR, 28.0-156.0] vs. 40.0 [IQR, 20.0-62.8]; P < 0.001), HADS-Anxiety (6.0 [IQR, 3.3-9.0] vs. 5.0 [IQR, 3.0-7.0]; P = 0.003), higher HADS-Depression scores (6.0 [IQR, 3.0-9.0] vs. 3.0 [IQR, 1.0-5.0]; P < 0.001), CSI (67.2 [SD, 15.0] vs. 57.4 [SD, 12.5]; P = 0.002), WHODAS-2.0 (41.0 [IQR, 15.5-68.5] vs. 22.0 [IQR, 10.0-35.0]; P < 0.001), and NDI (21.0 [IQR, 16.0-27.0] vs. 14.5 [IQR, 8.0-22.0]; P = 0.007). No marked differences were noted between the PTH group and chronic migraine groups.ConclusionsPersons with persistent PTH show similar disability and headache profiles to those with chronic migraine. These findings underscore the need for targeted management strategies, similar to those used in chronic migraine care.
期刊介绍:
Cephalalgia contains original peer reviewed papers on all aspects of headache. The journal provides an international forum for original research papers, review articles and short communications. Published monthly on behalf of the International Headache Society, Cephalalgia''s rapid review averages 5 ½ weeks from author submission to first decision.